Anixa Biosciences (formerly known as ITUS Corporation) is a biotechnology company providing diagnostic and therapeutic solutions for the early detection of tumor-based cancers. It develops a diagnostic platform called Cchek, a series of non-invasive blood tests which can be used for conventional screening, confirmatory testing, and treatment and recurrence monitoring. The Company also develops chimeric antigen receptor T-cell (CAR-T) based immunotherapy drugs which genetically engineer a patient’s own immune cells to fight cancer.